Approved comparison material connected to this topic.
21 total recordsSource comparisons are presented without a generated winner.
Clinical Research Standard 100mcg 5 days/week 30–60 min pre-sleep Saturates receptors without receptor downregulation. Ideal for sustained metabolic benefit Performance Research (Advanced) 200mcg 7 days/week M…
Clinical trials investigating GHRH-GHRP combinations consistently used 1–2mcg/kg body weight for each peptide, administered subcutaneously. For a 75kg individual, that translates to 75–150mcg of CJC-1295 no DA…
Below is a comparison of standard research dosing protocols documented in peer-reviewed growth hormone secretagogue studies, showing how dosage varies by research objective and administration timing. Standard …
Dosage and concentration are not interchangeable terms. Dosage refers to the amount of active peptide administered per injection, while concentration describes how much peptide exists per milliliter of reconst…
Research applications of CJC-1295 no DAC & Ipamorelin dosage protocols fall into two primary categories: monotherapy (single peptide) and combination therapy (both peptides co-administered). Monotherapy protoc…
The following table outlines the most common research dosing protocols for CJC-1295 no DAC and Ipamorelin, comparing single-peptide and combination approaches across key parameters. CJC-1295 Monotherapy 200-30…
CJC-1295 without DAC (modified GRF 1-29) has a plasma half-life of approximately 30 minutes. Short enough that it clears the system within 2–3 hours post-injection. This rapid clearance preserves the pulsatile…
Standard Dose Range 100–200 mcg per injection 200–300 mcg per injection Both compounds administered simultaneously in separate syringes Injection Frequency 1–3 times daily Matched timing. Morning + pre-sleep m…
100mcg : 100mcg First-line sleep enhancement protocol 12-18% delta wave power increase 65-70% report subjective improvement within 7-10 nights 30-60 min pre-sleep Optimal starting dose for most individuals. Lo…
Single Injection Dose 100-300mcg subcutaneously 200-300mcg subcutaneously 200mcg CJC + 250mcg Ipa per injection 200/250mcg pairing maximises synergistic GH pulse amplitude without overshooting receptor saturat…
Conservative Research Protocol 150mcg Once daily (pre-bed) 1.05mg Suitable for initial tolerance assessment. Produces measurable GH pulse elevation without exceeding receptor saturation. Limited lipolytic effe…
The table below compares three dosing protocols across clinical efficacy, injection frequency, and practical implementation. The 'Professional Assessment' column reflects our evaluation after reviewing publish…
| Protocol Type | CJC-1295 no DAC Dose | Ipamorelin Dose | Frequency | Total Daily Exposure | Optimal Use Case | Professional Assessment ||—|—|—|—|—|—|| Conservative Starter | 100mcg | 100mcg | 2x daily (AM, P…
Conservative Entry 100–150mcg 3x/week Before bed (non-training days) +20–30% Best for first-time users or those over 60. Minimises side effects while establishing baseline response Standard Anti-Aging 200–300m…
| Protocol Type | CJC-1295 Dose | Ipamorelin Dose | Frequency | Expected IGF-1 Increase | Receptor Tolerance Risk | Professional Assessment ||—|—|—|—|—|—|| Conservative Starter | 100mcg | 100mcg | Nightly (7 d…
Pre-Sleep Only 100–150mcg 200–250mcg 20–30 min before bed Maximizes overnight repair, extends slow-wave sleep General recovery, injury healing, sleep optimization Best single-dose option for most users. Aligns…
Conservative (Beginner) 100mcg 200mcg 1× daily (pre-bed) 20–35% Lower side effect risk, slower results Best starting point for peptide-naive individuals. Allows assessment of individual response Standard (Inte…
Before selecting a dosing protocol, researchers should understand how frequency, timing, and adjunct compounds affect outcomes. The table below compares the three most common approaches. Conservative Single Do…
This table compares the three most common CJC-1295 no DAC & Ipamorelin sleep protocols used in research settings as of 2026, including dosage ranges, timing windows, administration frequency, and observed outc…
CJC-1295 without DAC (also called Mod GRF 1-29) has a plasma half-life of approximately 30 minutes, producing a sharp GH pulse that clears within 2–3 hours. CJC-1295 with DAC extends the half-life to 6–8 days …